Multidisciplinary Prerounding Meeting as a Continuous Quality Improvement Tool: Leveraging to Reduce Continuous Benzodiazepine Use at an Academic Medical Center.
Benzodiazepines
/ administration & dosage
Conscious Sedation
/ methods
Drug Utilization
/ standards
Humans
Infusions, Intravenous
/ methods
Intensive Care Units
/ standards
Interdisciplinary Communication
Quality Assurance, Health Care
Quality Improvement
/ organization & administration
Respiration, Artificial
Teaching Rounds
/ methods
United States
benzodiazepine
critical care
implementation science
multidisciplinary
quality improvement
Journal
Journal of intensive care medicine
ISSN: 1525-1489
Titre abrégé: J Intensive Care Med
Pays: United States
ID NLM: 8610344
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
pubmed:
24
4
2018
medline:
24
1
2020
entrez:
24
4
2018
Statut:
ppublish
Résumé
Evidence-based medicine often has many barriers to overcome prior to implementation in practice, hence the importance of continuous quality improvement. We report on a brief (≤10 minutes) multidisciplinary meeting prior to rounds to establish a dashboard for continuous quality improvement and studied the success of this meeting on a particular area of focus: continuous infusion benzodiazepine minimization. This was a prospective observational study of patients admitted to the medical intensive care unit (MICU) of a large academic medical center over a 4-month period. A morning multidisciplinary prerounding meeting was implemented to report on metrics required to establish a dashboard for MICU care for the previous 24 hours. Fellows and nurse practitioners on respective teams reported on key quality metrics and other important data related to patient census. Continuous benzodiazepines were tracked daily as the number of patients per team who had orders for a continuous benzodiazepine infusion. The aim of this report is to describe the development of the morning multidisciplinary prerounding meeting and its impact on continuous benzodiazepine use, along with associated clinical outcomes. The median number of patients prescribed a continuous benzodiazepine daily decreased over this time period and demonstrated a sustained reduction at 1 year. Furthermore, sedation scores improved, corresponding to a reduction in median duration of mechanical ventilation. The effectiveness of this intervention was mapped post hoc to conceptual models used in implementation science. A brief multidisciplinary meeting to review select data points prior to morning rounds establishes mechanisms for continuous quality improvement and may serve as a mediating factor for successful implementation when initiating and monitoring practice change in the ICU.
Sections du résumé
BACKGROUND
BACKGROUND
Evidence-based medicine often has many barriers to overcome prior to implementation in practice, hence the importance of continuous quality improvement. We report on a brief (≤10 minutes) multidisciplinary meeting prior to rounds to establish a dashboard for continuous quality improvement and studied the success of this meeting on a particular area of focus: continuous infusion benzodiazepine minimization.
METHODS
METHODS
This was a prospective observational study of patients admitted to the medical intensive care unit (MICU) of a large academic medical center over a 4-month period. A morning multidisciplinary prerounding meeting was implemented to report on metrics required to establish a dashboard for MICU care for the previous 24 hours. Fellows and nurse practitioners on respective teams reported on key quality metrics and other important data related to patient census. Continuous benzodiazepines were tracked daily as the number of patients per team who had orders for a continuous benzodiazepine infusion. The aim of this report is to describe the development of the morning multidisciplinary prerounding meeting and its impact on continuous benzodiazepine use, along with associated clinical outcomes.
RESULTS
RESULTS
The median number of patients prescribed a continuous benzodiazepine daily decreased over this time period and demonstrated a sustained reduction at 1 year. Furthermore, sedation scores improved, corresponding to a reduction in median duration of mechanical ventilation. The effectiveness of this intervention was mapped post hoc to conceptual models used in implementation science.
CONCLUSIONS
CONCLUSIONS
A brief multidisciplinary meeting to review select data points prior to morning rounds establishes mechanisms for continuous quality improvement and may serve as a mediating factor for successful implementation when initiating and monitoring practice change in the ICU.
Identifiants
pubmed: 29683053
doi: 10.1177/0885066618769015
doi:
Substances chimiques
Benzodiazepines
12794-10-4
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
707-713Subventions
Organisme : British Heart Foundation
ID : RG/12/12/29872
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0700320
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K003232/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/C503646/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/17/16/33294
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0600785
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R01065X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000458
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/11/45/28859
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R01065X/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L009684/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/10/98/28655
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P023150/2
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/15/26/31373
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/13/13/30018
Pays : United Kingdom
Organisme : British Heart Foundation
ID : IG/16/2/32273
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/17/44/33064
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P023150/1
Pays : United Kingdom